You just read:

Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

News provided by

Bayer HealthCare

Feb 11, 2013, 07:51 ET